The role of super(18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours

Purpose: In lung cancer patients with multiple lesions, the differentiation between metastases and second primary tumours has significant therapeutic and prognostic implications. The aim of this retrospective study was to investigate the potential of super(18)F-FDG PET to discriminate metastatic dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of nuclear medicine and molecular imaging 2010-11, Vol.37 (11), p.2037-2047
Hauptverfasser: Dijkman, Bernadette G, Schuurbiers, Olga CJ, Vriens, Dennis, Looijen-Salamon, Monika, Bussink, Johan, Timmer-Bonte, Johanna NH, Snoeren, Miranda M, Oyen, Wim JG, Heijden, Henricus FM, Geus-Oei, Lioe-Fee
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose: In lung cancer patients with multiple lesions, the differentiation between metastases and second primary tumours has significant therapeutic and prognostic implications. The aim of this retrospective study was to investigate the potential of super(18)F-FDG PET to discriminate metastatic disease from second primary lung tumours. Methods: Of 1,396 patients evaluated by the thoracic oncology group between January 2004 and April 2009 at the Radboud University Nijmegen Medical Centre, patients with a synchronous second primary lung cancer were selected. Patients with metastatic disease involving the lungs served as the control group. Maximum standardized uptake values (SUVs) measured with super(18)F-FDG PET were determined for two tumours in each patient. The relative difference between the SUVs of these tumours ( Delta SUV) was determined and compared between the second primary group and metastatic disease group. Receiver-operating characteristic (ROC) curve analysis was performed to determine the sensitivity and specificity of the Delta SUV for an optimal cut-off value. Results: A total of 37 patients (21 metastatic disease, 16 second primary cancer) were included for analysis. The Delta SUV was significantly higher in patients with second primary cancer than in those with metastatic disease (58 vs 28%, respectively, p
ISSN:1619-7070
1619-7089
DOI:10.1007/s00259-010-1505-2